LINC01415: A Drug Target / Disease Biomarker (G100132501)

Target Name: LINC01415

NCBI ID: G100132501

LINC01415

Other Name(s): long intergenic non-protein coding RNA 1415 | Long intergenic non-protein coding RNA 1415, transcript variant 1 | TCONS_00026208

LINC01415: A Drug Target / Disease Biomarker

LINC01415 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to be involved in the regulation of cell growth and differentiation.

One of the most promising aspects of LINC01415 is its potential as a drug target. The protein is known to be involved in the development and maintenance of cancer, and there is a growing interest in using small molecules to disrupt its activity and inhibit its growth.

One approach that researchers have taken to study LINC01415 is to use high-throughput screening techniques to identify small molecules that can interact with the protein. These studies have led to the identification of a number of potential compounds that can inhibit LINC01415's activity.

While the exact mechanism of LINC01415's activity is not yet fully understood, it is thought to play a role in the regulation of cell proliferation and survival. There is evidence that LINC01415 is involved in the development and maintenance of cancer, and that its activity may be increased in these conditions.

In addition to its potential as a drug target, LINC01415 also has potential as a biomarker. The protein is expressed in a wide range of tissues and cells, and its levels can be used as a proxy for the health and function of these cells. This makes it an attractive candidate for use as a diagnostic or predictive marker in a variety of diseases.

Overall, LINC01415 is a promising protein for study as a drug target and biomarker. Further research is needed to fully understand its function and potential clinical applications.

Protein Name: Long Intergenic Non-protein Coding RNA 1415

The "LINC01415 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01415 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets